The I2 estimate revealed significant heterogeneity (I2 = 53%) among the studies, and the random effects model used in thismeta-analysis indicated that the expression of EpCAM in the gastric cancer group was greater than that in the control group. Here, EPCAM is linked to gastric cancer.